10-Q Filing

CARDINAL HEALTH INC CIK: 721371 Q1 2024

Filing Information

Form Type	10-Q
Accession Number	`0000721371-23-000084`
Period End Date	20230930
Filing Date	20231103
Fiscal Year	2024
Fiscal Period	Q1
XBRL Instance	cah-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 42 Cash Flow Statement 54 Stockholders Equity 37 Comprehensive Income 14

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.04B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.85B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$11.27B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$11.34B	USD	Point-in-time
Inventories, net	`InventoryNet`	$16.99B	USD	Point-in-time
Inventories, net	`InventoryNet`	$15.94B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$2.36B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$2.58B	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperation`	-	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperation`	$144.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$34.69B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$33.83B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.46B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.44B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$5.43B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$6.08B	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$1.04B	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$1.15B	USD	Point-in-time
Total assets	`Assets`	$43.71B	USD	Point-in-time
Total assets	`Assets`	$43.42B	USD	Point-in-time
Accounts Payable, Current	`AccountsPayableCurrent`	$31.54B	USD	Point-in-time
Accounts Payable, Current	`AccountsPayableCurrent`	$29.81B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$792.00M	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$788.00M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.74B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$3.06B	USD	Point-in-time
Liabilities related to assets held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation`	-	USD	Point-in-time
Liabilities related to assets held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation`	$42.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$35.06B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$33.71B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$3.89B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$3.91B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$8.24B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$8.65B	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Value, Issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, Value, Issued	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$2.75B	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$2.73B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-534.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-654.00M	USD	Point-in-time
Treasury Stock, Value	`TreasuryStockValue`	$4.91B	USD	Point-in-time
Treasury Stock, Value	`TreasuryStockValue`	$5.40B	USD	Point-in-time
Treasury Stock, Shares	`TreasuryStockCommonShares`	76.00M	shares	Point-in-time
Treasury Stock, Shares	`TreasuryStockCommonShares`	80.00M	shares	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-151.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-165.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' deficit	`StockholdersEquity`	$-3.49B	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' deficit	`StockholdersEquity`	$-2.85B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$1.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$1.00M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.78B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.49B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.85B	USD	Point-in-time
Total liabilities and shareholders deficit	`LiabilitiesAndStockholdersEquity`	$43.71B	USD	Point-in-time
Total liabilities and shareholders deficit	`LiabilitiesAndStockholdersEquity`	$43.42B	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$54.76B	USD	1 Quarter
Revenue	`Revenues`	$49.60B	USD	1 Quarter
Cost of Goods and Services Sold	`CostOfGoodsAndServicesSold`	$52.99B	USD	1 Quarter
Cost of Goods and Services Sold	`CostOfGoodsAndServicesSold`	$47.99B	USD	1 Quarter
Gross margin	`GrossProfit`	$1.77B	USD	1 Quarter
Gross margin	`GrossProfit`	$1.61B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.20B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.20B	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$25.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$29.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$64.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$71.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-537.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-153.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$41.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-27.00M	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$-14.00M	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$137.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-2.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$2.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$14.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$25.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-26.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$110.00M	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-1.00M	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-32.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$111.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$6.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$5.00M	USD	1 Quarter
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$110.00M	USD	1 Quarter
Basic (in shares)	`EarningsPerShareBasic`	$0.41	USD	1 Quarter
Basic (in shares)	`EarningsPerShareBasic`	$0.02	USD	1 Quarter
Diluted (in shares)	`EarningsPerShareDiluted`	$0.40	USD	1 Quarter
Diluted (in shares)	`EarningsPerShareDiluted`	$0.02	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	249.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	271.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	250.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	273.00M	shares	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$111.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$6.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$171.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$172.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-537.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-153.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$23.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$29.00M	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$29.00M	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$29.00M	USD	1 Quarter
(Increase)/decrease in trade receivables	`IncreaseDecreaseInReceivables`	$508.00M	USD	1 Quarter
(Increase)/decrease in trade receivables	`IncreaseDecreaseInReceivables`	$-50.00M	USD	1 Quarter
Increase in inventories	`IncreaseDecreaseInInventories`	$264.00M	USD	1 Quarter
Increase in inventories	`IncreaseDecreaseInInventories`	$1.06B	USD	1 Quarter
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.73B	USD	1 Quarter
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.23B	USD	1 Quarter
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$948.00M	USD	1 Quarter
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$926.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$545.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$23.00M	USD	1 Quarter
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$70.00M	USD	1 Quarter
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$92.00M	USD	1 Quarter
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$1.00M	USD	1 Quarter
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$3.00M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$1.00M	USD	1 Quarter
Proceeds from investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$1.00M	USD	1 Quarter
Proceeds from investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$1.00M	USD	1 Quarter
Proceeds from Hedge, Investing Activities	`ProceedsFromHedgeInvestingActivities`	-	USD	1 Quarter
Proceeds from Hedge, Investing Activities	`ProceedsFromHedgeInvestingActivities`	$28.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-63.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-70.00M	USD	1 Quarter
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$7.00M	USD	1 Quarter
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$7.00M	USD	1 Quarter
Net tax withholdings from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-14.00M	USD	1 Quarter
Net tax withholdings from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-28.00M	USD	1 Quarter
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$142.00M	USD	1 Quarter
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$131.00M	USD	1 Quarter
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$500.00M	USD	1 Quarter
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$1.00B	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-666.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.16B	USD	1 Quarter
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-5.00M	USD	1 Quarter
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-15.00M	USD	1 Quarter
Net decrease in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.23B	USD	1 Quarter
Net decrease in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-189.00M	USD	1 Quarter
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.85B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.04B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.72B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.49B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.85B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.04B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.72B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.49B	USD	Point-in-time

Stockholders Equity 37 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.78B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.49B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.85B	USD	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	76.00M	shares	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	80.00M	shares	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$4.91B	USD	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$5.40B	USD	Point-in-time
Net earnings	`NetIncomeLoss`	$5.00M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$110.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$111.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$6.00M	USD	1 Quarter
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-14.00M	USD	1 Quarter
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-62.00M	USD	1 Quarter
Purchase of noncontrolling interests	`MinorityInterestDecreaseFromRedemptions`	$2.00M	USD	1 Quarter
Employee stock plans activity, net of shares withheld for employee taxes	`StockIssuedDuringPeriodValueShareBasedCompensation`	$11.00M	USD	1 Quarter
Employee stock plans activity, net of shares withheld for employee taxes	`StockIssuedDuringPeriodValueShareBasedCompensation`	-	USD	1 Quarter
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$500.00M	USD	1 Quarter
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$1.00B	USD	1 Quarter
Share repurchase program activity	`TreasuryStockValueAcquiredCostMethod`	$505.00M	USD	1 Quarter
Share repurchase program activity	`TreasuryStockValueAcquiredCostMethod`	$1.00B	USD	1 Quarter
Dividends	`Dividends`	$131.00M	USD	1 Quarter
Dividends	`Dividends`	$125.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	$-1.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	$-1.00M	USD	1 Quarter
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.78B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.49B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.85B	USD	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockCommonShares`	76.00M	shares	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockCommonShares`	80.00M	shares	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$4.91B	USD	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$5.40B	USD	Point-in-time

Comprehensive Income 14 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$111.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$6.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-58.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-11.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-3.00M	USD	1 Quarter
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-62.00M	USD	1 Quarter
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-14.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$49.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-8.00M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-9.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$48.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.